193 related articles for article (PubMed ID: 24555480)
1. Current patterns of presentation and treatment of renal masses: a clinical research office of the endourological society prospective study.
Laguna MP; Algaba F; Cadeddu J; Clayman R; Gill I; Gueglio G; Hohenfellner M; Joyce A; Landman J; Lee B; van Poppel H;
J Endourol; 2014 Jul; 28(7):861-70. PubMed ID: 24555480
[TBL] [Abstract][Full Text] [Related]
2. Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.
Filson CP; Schwartz K; Colt JS; Ruterbusch J; Linehan WM; Chow WH; Miller DC
Urol Oncol; 2014 Jan; 32(1):27.e15-21. PubMed ID: 23419677
[TBL] [Abstract][Full Text] [Related]
3. [Partial elective nephrectomy].
Zungri E; Martínez L; Leal D; Lorenzo L
Actas Urol Esp; 2012 Mar; 36(3):160-4. PubMed ID: 21955560
[TBL] [Abstract][Full Text] [Related]
4. A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project).
Schiavina R; Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Brunocilla E; Fiori C; Longo N; Martorana G; Mirone V; Morgia G; Novara G; Porpiglia F; Rovereto B; Serni S; Simeone C; Sodano M; Terrone C; Carini M; Minervini A
Eur J Surg Oncol; 2015 Mar; 41(3):346-52. PubMed ID: 25583459
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
[TBL] [Abstract][Full Text] [Related]
6. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
[TBL] [Abstract][Full Text] [Related]
7. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
[TBL] [Abstract][Full Text] [Related]
8. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Decision Making for Nephron-Sparing Procedure in the Renal Mass: Time for Using Standard Tools?
Zondervan PJ; van Lienden KP; van Delden OM; de la Rosette JJ; Laguna MP
J Endourol; 2016 Jan; 30(1):128-34. PubMed ID: 26413831
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
[TBL] [Abstract][Full Text] [Related]
11. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
[TBL] [Abstract][Full Text] [Related]
12. Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.
Fernando A; Fowler S; O'Brien T;
BJU Int; 2016 Jun; 117(6):874-82. PubMed ID: 26469291
[TBL] [Abstract][Full Text] [Related]
13. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
14. Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.
Larcher A; Capitanio U; Terrone C; Volpe A; De Angelis P; Dehó F; Fossati N; Dell'Oglio P; Antonelli A; Furlan M; Simeone C; Serni S; Carini M; Minervini A; Fiori C; Porpiglia F; Briganti A; Montorsi F; Bertini R
J Urol; 2016 Oct; 196(4):1008-13. PubMed ID: 27235789
[TBL] [Abstract][Full Text] [Related]
15. Novel kidney segmentation system to describe tumour location for nephron-sparing surgery.
Papalia R; De Castro Abreu AL; Panebianco V; Duddalwar V; Simone G; Leslie S; Guaglianone S; Tejura T; Ferriero M; Costantini M; Desai M; Gallucci M; Gill IS
World J Urol; 2015 Jun; 33(6):865-71. PubMed ID: 25159872
[TBL] [Abstract][Full Text] [Related]
16. Nephron-sparing surgery in the treatment of pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions.
Liu C; Zhang W; Song H
J Pediatr Surg; 2017 Sep; 52(9):1492-1495. PubMed ID: 28365106
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
18. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
Pertia A; Managadze L; Chkhotua A
Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
[TBL] [Abstract][Full Text] [Related]
19. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
